Michael Thomas Heffernan - Insider Trading & Ownership

Location
C/O Cornerstone Therapeutics Inc., 1255 Crescent Green Drive, Suite 250, Cary, NC
Summary
The estimated net worth of Michael Thomas Heffernan is at least $1.6M dollars as of July 10, 2025. Michael Thomas Heffernan is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.54M. Michael Thomas Heffernan is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $59.4K.
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All Insider Reports
All Insider Reports

Notify me when Michael Thomas Heffernan files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Michael Thomas Heffernan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $1.54M Feb 10, 2025
AKBA Akebia Therapeutics, Inc. Director $59.4K Jun 2, 2021
AVTX Avalo Therapeutics, Inc. Director Jun 17, 2025
BHVN Biohaven Ltd. Director May 5, 2025
BHVN Biohaven Pharmaceutical Holding Co Ltd. Director Oct 3, 2022
ENGN, ENGNW enGene Holdings Inc. Director Jul 8, 2025
SYBX SYNLOGIC, INC. Director Jun 22, 2023
TRVI Trevi Therapeutics, Inc. Director Jun 11, 2025

Insider Transactions Reported by Michael Thomas Heffernan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.